Lactobacillus rhamnosus MP108

High Gastric Acid and Bile Tolerance:

MP108 remained high bioavailability in the simulated environment with Gastric Acid and Bile for 7 hours.

Strong Colonization on Caco-2 Intestine Cells:

MP108 highly adheres to Caco-2 intestine cells

Improve Diarrhea and Constipation:

Infants and young children suffering diarrhea (>3 times a day) were given MP108 ( 5×109CFU/day) (blue bar) or MP108 probiotic combined with antibiotics (orange bar) for 7 days, and the result shows that MP108 can improve the symptoms of diarrhea.

80 subjects with severe diarrhea ( Less than 3 times of defecation) took MP108 ( 10 billion cfu/day), administration 4 weeks.

Improve Allergic Symptoms:

Clinical Trial : 59 subjects aged 6-13 years old with Chronic rhinitis took MP108 ( 5 billion cfu/day) with antihistamine for the first 30 days, and stop taking antihistamine during the following 60 days, but MP108 alone.

Improve Atopic Dermatitis:

Clinical Trial: 66 infants aged 4-48 months with dermatitis took MP108 (5 billion cfu/day) and applied topical corticosteroids. Administration 8 weeks.

 Clinical Study: on 62 infants and young children aged 4-48 months and diagnosed with atopic dermati with a Scoring of Atopic Dermatitis (SCORAD) ≥ 15, conducted for 8 weeks, with 32 subjects in control group (placebo) and 30 subjects in probiotics group (MP108) (* p < 0.05 vs. control group):

MP108 could improve atopic dermatitis:

MP108 could reduce the intensity of atopic dermatitis

Clinical Study on 59 children aged 6-13 years and diagnosed with allergic rhinitis for > 1 year with medium to severe symptoms, conducted for 90 days, with administration of antihistamine therapy and MP108 capsules during the first 30 days and MP108 capsules only during the other 60 days:

MP108 helps improve symptoms of allergic rhinitis

MP108 helps reduce nasal airway resistance